AstraZeneca Bid to Supplant Lipitor Not Curing Stock (Update1) (Bloomberg.com)

April 17 (Bloomberg) — AstraZeneca Plc is entering a final phase in an unprecedented research program to prove its Crestor cholesterol pill is better than Pfizer Inc.’s Lipitor.



[News Source]


   Posted in Lipitor lawsuit    






AstraZeneca Bid to Supplant Lipitor Not Curing Stock (Update1) (Bloomberg.com)

April 17 (Bloomberg) -- AstraZeneca Plc is entering a final phase in an unprecedented research program to prove its Crestor cholesterol pill is better than Pfizer Inc.'s Lipitor.

[News Source]


   Posted in Lipitor lawsuit